Clincosm LogoSign in Get a demo

c04.588.274.476.411.307

Showing 1 - 2 of 2
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

C04.588.274.476.411.307 Trial (CPI-613, modified FFX, Bevacizumab)

Not yet recruiting
  • C04.588.274.476.411.307
  • (no location specified)
Nov 10, 2022

C04.588.274.476.411.307 Trial in Denmark, Sweden (Oxaliplatin (Eloxatin), Capecitabine (Xeloda))

Completed
  • C04.588.274.476.411.307
  • Oxaliplatin (Eloxatin)
  • Capecitabine (Xeloda)
  • Esbjerg, Denmark
  • +7 more
Nov 4, 2020